The safety and efficacy of Methylene Blue MMX modified release tablets administered to subjects undergoing screening or surveillance colonoscopy.
Phase of Trial: Phase III
Latest Information Update: 07 Feb 2017
At a glance
- Drugs Methylthioninium chloride-Cosmo (Primary)
- Indications Adenoma; Colon cancer
- Focus Diagnostic use; Registrational
- Sponsors Cosmo Pharmaceuticals
- 31 Jan 2017 Status changed to completed.
- 28 Jul 2016 Planned End Date changed from 1 Jun 2016 to 1 Sep 2016.
- 28 Jul 2016 Planned primary completion date changed from 1 May 2016 to 1 Sep 2016.